Compared with people in the healthy control group, significant increases in CD38+ HLA-DR+ CD8+ cells and CD4+T cells were found in patients with MIS-C and MAS due to other causes (Figure 5, A and B). This evidence concerns the gene CD38 and macrophage activation syndrome.